Diagnostics
-
Healthcare Hires of Note
Read about executive hires across healthcare and life sciences.
-
A Preview of Healthcare Startups at HLTH 2022
Startups will be plentiful at the upcoming HLTH conference at the Venetian Expo in Las Vegas November 13-16. Here’s a glimpse of some of the healthcare pain points they’re addressing.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
FDA narrows EUAs for Covid-19 tests, steering companies to traditional review pathways
The FDA said it will review fewer Covid-19 diagnostics for emergency use authorization. The policy update follows an Office of Inspector General report that found the urgency to increase testing availability led to problems, including the authorization of many low-quality tests.
-
BioMEMS founder shares his vision for changing how diagnostics are developed, deployed and administered
Andrew Dahl, founder and chairman of BioMEMS Diagnostics, shared how his business seeks to transform the diagnostics sector, in response to emailed questions.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from BioMEMS Diagnostics, Neuroflow, Druglike, Health Note, and Rhinostics.
-
Devices & Diagnostics, BioPharma
LabCorp plans to break out its $6B drug development biz as a standalone company
Laboratory testing and clinical trial services giant LabCorp plans to spin off its drug development business as an independent, publicly traded company. It’s the latest in a string of corporate moves for the life sciences sector as companies look to streamline operations in order to focus on particular areas of growth.
-
StartUPDATES: New developments from healthcare startups
Check out new developments from Seven Bridges, Healthmine, Bright Health, and My One Medical Source.
-
Pandemic Response Lab CEO discusses its approach to laboratory automation
In addition to developing rapid testing for Covid-19, PRL has developed a non-diagnostic sequencing workflow for rapid variant detection and tracking.
-
BioPharma, Devices & Diagnostics, SYN
Sherlock Biosciences secures $80M to bring molecular diagnostics to the home
Diagnostics developer Sherlock Biosciences has advanced its molecular diagnostic capabilities, which can now produce faster results on low-cost devices. The startup will use its Series B round of funding to expand the reach of its technology, potentially placing it directly in the hands of consumers around the world.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Devices & Diagnostics, Artificial Intelligence
Freenome gets $290M from Roche as it preps blood-based cancer test’s next steps
A month after Freenome closed $300 million in financing, Roche has invested another $290 million in the diagnostics developer. The cash infusion comes as Freenome continues a pivotal test in colorectal cancer while it also readies for clinical trials in other types of cancer.
-
Time is running out to apply to pitch your healthcare startup at MedCity INVEST
The deadline to apply to the MedCity INVEST Pitch Perfect contest in Chicago, scheduled for March 28-30 at the Ritz Carlton, is January 31.
-
As genetic testing expands, evidence and awareness needed to spur adoption
Genetic tests are becoming available for a wider range of applications. During a CB Insights panel discussion, Phil Febbo of Illumina and Alicia Zhou of Color explained what they think needs to happen to make these tests accessible and affordable for more people.
-
A preview of MedCity INVEST 2022: A return to in-person conferences
INVEST, scheduled for March 28-30, 2022 in Chicago, marks a return to in-person events for MedCity News. The conference, held in partnership with Mid-America Healthcare Investors Network, will spotlight healthcare innovation, investment trends, and share insights from healthcare executives.
-
Devices & Diagnostics, Diagnostics
GE plans to spin out healthcare business in 2023
General Electric plans to spin out its healthcare business into a publicly traded entity in 2023. It’s part of a broader restructuring as the company looks to turn around its business.
-
A call for patients to resume routine cancer screenings and treatment
During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
